期刊文献+

纤溶和凝血因子在急性肺血栓栓塞症发病机制中的作用 被引量:1

Study on Plasma Concentration of Coagulation and Fibrinolytic Parameters in Acute Pulmonary Thromboembolism
下载PDF
导出
摘要 目的:测定急性肺血栓栓塞症(APT)患者凝血和纤溶因子的血浆含量,探讨其在发病机制中的作用。方法:对44例APT患者(APT组)和56例健康查体者(对照组)应用酶联免疫吸附双抗体夹心法(ELISA法)定量测定血浆tPA、PAI-1、PC、FPS和vWF∶Ag抗原水平。结果:与对照组相比,APT组tPA、PAI-1和vWF∶Ag血浆含量水平较高,FPS水平较低,且差别有显著统计学意义。结论:PAI-1及vWF∶Ag产生、释放增多和FPS血浆含量减低在急性肺血栓栓塞症的发病机制中具有重要作用。 Objective To explore the changes and the roles of coagulation and fibrinolytic parameters in acute pulmonary thromboembolism APT. Methods The antigen levels of tPA,PAI-1,PC,FPS and vWF∶Ag were quantified by a commercially available enzyme-linked immunosorbent assay ELISA respectively in various therapytic periods of 44 APT cases and 56 healthy control cases. Results APT patients had higher levels of tPA,PAI-1 and vWF antigen and lower levels of FPS before the starting of therapy than thoes of healthy-control group. Conclusions Increased PAI-1 and vWF antigen levels and decreased FPS level in plasma may contribute to the incidence of APT.
出处 《天津医药》 CAS 北大核心 2005年第7期403-404,共2页 Tianjin Medical Journal
基金 天津市自然科学基金重点资助项目(项目编号:013609011)
  • 相关文献

参考文献6

  • 1Siren V, Kauhanen P, Carpen O, et al. Urokinase, tissue-type plasminogen and plasminogen activator inhibitor-Ⅰ expression in severely stenosd and oclluded vein grafts with thrombosis. Blood Coagul Fibrinolysis, 2003,14:369-377.
  • 2Swgui R, Estelles A, Mira Y, et al. PAI-Ⅰ promotor 4G/5G genetype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol, 2000, 111:122-128.
  • 3庞宝森,王辰,罗琴,张黎明,朱敏,毛燕玲,黄秀霞,郭文敬.实验性肺血栓栓塞症后凝血纤溶系统及肺血管内皮功能变化的临床意义[J].中华结核和呼吸杂志,2004,27(6):381-384. 被引量:28
  • 4O'Brien JR, Etherington MD. The endothelial von Willebrand factor in venous occlusion blood. Thromb Haemost,1997, 78:1528-1529.
  • 5Kamphuisen PW, Eikenboom JC, Rosendaal FR, et al. High factor Ⅷ antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor Ⅷ gene. Br J Haematol, 2001,115:156-158.
  • 6Langlois N J, Wells PS. Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review.Thromb Haemost, 2003, 90:17-26.

二级参考文献5

  • 1Dalen JE, Alpert JS.Thrombolytic therapy for pulmonary embolism. Arch Intern Med, 1997, 1578:2550-2556.
  • 2Huber K. Plasminogen activator inhibitor type-1(part one): basic mechanisms, regulation, and role of thromboembolic disease. J Thromb Thrombolysis, 2001,11:183-193.
  • 3Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiologic function. Am Rev Cell Biol, 1998, 4: 93-126.
  • 4Hoyer LW. The factor Ⅷ comonary hypertention:cell biology and pathphysiology.Chest,1994,106:236-239.
  • 5Micheal JR, Markewitz BA. Endothelins and the lung. Am J Respir Crit Care Med,1996,154:555-581.

共引文献27

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部